
==== Front
Tremor Other Hyperkinet Mov (N Y)
Tremor Other Hyperkinet Mov (N Y)
2160-8288
Tremor and Other Hyperkinetic Movements
2160-8288
Ubiquity Press

10.5334/tohm.935
VoR
Review
Beyond Pallidal or Subthalamic Deep Brain Stimulation to Treat Dystonia
https://orcid.org/0000-0002-0519-1673
Garg Vedant 1
https://orcid.org/0009-0001-7046-5431
Lavu Venkat Srikar 1
https://orcid.org/0000-0002-9838-7738
Hey Grace 1
Winter Brett 1
Firme Marcos Santana 1
https://orcid.org/0000-0002-9688-057X
Hilliard Justin D. 2
https://orcid.org/0000-0003-2780-3666
De Hemptinne Coralie 1
https://orcid.org/0000-0002-6247-9358
Okun Michael S. 1
https://orcid.org/0000-0002-4632-3417
Wong Joshua K. MD Joshua.wong@neurology.ufl.edu
1
1 Department of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, USA
2 Department of Neurosurgery, Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, USA
17 9 2024
2024
14 4513 7 2024
09 9 2024
Copyright: © 2024 The Author(s)
2024
https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/.

Deep brain stimulation of the subthalamic nucleus and globus pallidus internus is approved by the Food and Drug Administration for treating dystonia. Both targets have shown effectiveness in improving symptoms, but post-operative outcomes can vary significantly among patients. This variability has led researchers to explore alternative neuromodulation targets that might offer more consistent results. Emerging research has highlighted several promising new targets for DBS in dystonia. This review examines pre-clinical and clinical data on novel DBS targets for dystonia and explores non-invasive neuromodulation studies that shed light on the disease’s underlying pathological circuitry.

dystonia
neuromodulation
deep brain stimulation
thalamus
cerebellum
Parkinson’s foundation 10.13039/100013301 The Michael J. Fox Foundation 10.13039/100000864 NIH 10.13039/100000002 UH3 NS115631 UH3 NS109556 R01 NR014852 R01 NS096008 UH3 NS119844 U01 NS119562 R25 NS108939 KL2TR001429 The Parkinson Alliance 10.13039/100013144 Smallwood Foundation Bachmann-Strauss Foundation Tourette Syndrome Association UF Foundation 10.13039/100001364 Dr. de Hemptinne receives funding support from the Parkinson’s foundation, The Michael J. Fox Foundation, and the NIH (UH3 NS115631 and UH3 NS109556). Dr. Okun serves as Medical Advisor the Parkinson’s Foundation, and has received research grants from NIH, Parkinson’s Foundation, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. Dr. Okun’s research is supported by: NIH R01 NR014852, R01 NS096008, UH3 NS119844, U01 NS119562. Dr. Okun is PI of the NIH R25 NS108939 Training Grant. Dr. Okun has received royalties for publications with Demos, Manson, Amazon, Smashwords, Books4 Patients, Perseus, Robert Rose, Oxford and Cambridge (movement disorders books). Dr. Okun is an associate editor for New England Journal of Medicine Journal Watch Neurology and JAMA Neurology. Dr. Okun has participated in CME and educational activities (past 12–24 months) on movement disorders sponsored by WebMD/Medscape, RMEI Medical Education, American Academy of Neurology, Movement Disorders Society, Mediflix and by Vanderbilt University. The institution and not Dr. Okun receives grants from industry. Dr. Okun has participated as a site PI and/or co-I for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria. Research projects at the University of Florida receive device and drug donations. Dr. Wong receives funding support from the NIH (KL2TR001429).
==== Body
pmcA brief history of deep brain stimulation for dystonia

Dystonia is a movement disorder characterized by muscle contractions that result in abnormal postures, repetitive movements, or both [1]. It is the third most common movement disorder, with the prevalence of primary dystonia reported at 16.43 per 100,000 [2]. Although the exact pathophysiology of dystonia is not entirely understood, the basal ganglia cerebello thalamo cortical loop (BGCT) plays a central role in this disease and has revealed possible targets for surgical interventions, including deep brain stimulation (DBS) [345]. DBS is an effective neuromodulatory therapy that involves the implantation of electrodes for chronic stimulation of brain tissue. DBS is safe and effective in well-selected and appropriately screened patients [6].

In the early 1950s, lesional neurosurgery using radiofrequency ablation emerged as a therapeutic modality to treat dystonia. Various central nervous system structures were targeted, such as the medial thalamus, dentate nucleus, globus pallidus internus (GPi), subthalamic nucleus (STN) and other basal ganglia [78]. After noticing that unilateral pallidotomy improved the medication OFF state in people with Parkinson’s disease, pallidal lesions were used to treat primary generalized dystonia [4910]. However, these lesions had significant limitations, particularly in treating axial symptoms with unilateral pallidotomy. Moreover, bilateral pallidotomy was linked to an increased risk of dysarthria, dysphagia, balance problems, and cognitive impairment [1011].

In 1977, Mundiner first used DBS to treat cervical dystonia, achieving moderate success [4]. Following this, bilateral GPi DBS was investigated for primary generalized and segmental dystonia [12131415]. In 2003, these efforts led to the Food and Drug Administration granting a humanitarian device exemption for STN and GPi DBS to treat patients with chronic, medically intractable dystonia [916]. Although the GPi has been the main target for DBS in dystonia patients, other targets such as the ventral intermediate nucleus (VIM) and the STN have also been effective alternatives in specific cases [8171819]. As our understanding of dystonia pathogenesis progresses towards a network-based disease model, substantial evidence supports the utility of several new targets [82021]. Here we define a network-based disease model as a condition where pathology or intervention in spatially distinct but interconnected brain regions impacts the same phenomenology, but in potentially different ways. Further, while GPi DBS can be effective for primary dystonias such as idiopathic or genetic dystonia, its efficacy on secondary dystonia such as post-stroke or tardive dystonia is less predictable, highlighting the need for alternative neuromodulation targets. In this review, we will explore the emerging and innovative targets for dystonia DBS beyond the already FDA-approved STN and GPi. We will also highlight noninvasive neuromodulation studies that have provided insight into the complex interplay of brain networks affected in dystonia (Figure 1). A complete review of the literature was undertaken using the PRISMA guidelines with the search strategy summarized in Figure 2 [22]. Our search terms can be seen in Supplemental Appendix 1.

Figure 1 The brain networks involved in dystonia.

The complex brain networks involved in the pathogenesis of dystonia are illustrated. These networks include the cerebello-thalamo-cortical network and basal ganglia-thalamo-cortical network. The ability to modulate these networks is also demonstrated here: transcranial direct current stimulation (red paddles), transcranial magnetic stimulation (black coil), and deep brain stimulation (blue leads).

The brain networks involved in dystonia

Figure 2 PRISMA flow diagram outlining search strategy and screening process.

The process of our literature review, including the criteria for inclusion and exclusion, is depicted below. This study was conducted in accordance with the PRISMA guidelines.

PRISMA flow diagram

The cerebellum

Several animal studies have suggested that the cerebellum may be involved in the development of dystonia and the associated motor problems. DYT-TOR1 A is an inherited form of dystonia caused by a mutation in the TorsinA protein. Fremont et al. found that a lack of TorsinA in the cerebellum, rather than the basal ganglia, led to dystonia in a mouse model of DYT-TOR1 A [23]. They also observed abnormal cerebellar activity associated with dystonic symptoms, indicating the central role of the cerebellum in DYT-TOR1 A-related motor issues [23]. In rat models, injecting kainic acid into the cerebellar vermis resulted in dystonic reactions, with the severity depending on the dosage [24]. These kainic acid injections, an excitatory glutamate receptor agonist, into the cerebellar vermis also caused alterations in the basal ganglia, demonstrating an underlying network dysfunction seen in dystonia. LeDoux et al. further explored this by performing cerebellectomies (CBX) in a dystonic rat model and found that it eliminated dystonic motor signs and improved motor function compared to the preoperative state [25]. Overall these studies provide supporting evidence that cerebellar pathology contributes to the motor symptoms in dystonia.

Given the growing collection of basic science research supporting the involvement of the cerebellum in dystonia, multiple studies have investigated noninvasive cerebellar stimulation in humans. Bradnam et al. studied 8 patients with focal hand dystonia (FHD) treated with cerebellar transcranial direct current stimulation (tDCS) for 20 minutes at a constant current of 2 mA. The patients treated with anodal tDCS demonstrated improved performance in handwriting speed, pen pressure during handwriting, and circle drawing tasks [26]. The improvement of dystonic symptoms was also observed in cerebellar tDCS in two cases of cervical dystonia. Nguyen et al. described a 77-year-old woman with cervical dystonia who was previously treated with botulinum toxin injections and motor cortex 10 Hz repetitive transcranial magnetic stimulation (rTMS) with an incomplete response [27]. She was then treated with five sessions of cerebellum anodal tDCS and experienced a significant reduction in pain and dystonic symptoms with a 67%–91% reduction in TWSTRS scores. Her improvements were sustained for two months. These benefits were noted most prominently following right cerebellar hemisphere stimulation. Bradnam et al. described a similar case in which a 47-year-old woman with a 15-year history of cervical dystonia was treated with tDCS in the cerebellum and primary motor cortex for 12 weeks [28]. The patient experienced a 55% reduction in the TWSTRS pain score, a 40% reduction in the craniocervical dystonia questionnaire (CDQ-24) and a 39% reduction in the cervical dystonia impact profile (CDIP-58).

Two sham-controlled trials using rTMS demonstrated that cerebellar theta burst stimulation (TBS) could modulate neuroplasticity and improve dystonic symptoms in cervical dystonia [2930]. Koch et al. tested the efficacy of continuous cerebellar TBS (pulse bursts every 200 ms for 40s) on 20 patients with cervical dystonia, while Bradnam et al. evaluated the effects of intermittent TBS (an interval pattern of a 2s TBS train repeated every 10 seconds) on 16 patients with cervical dystonia. Both studies found a statistically significant decrease in total TWSTRS score of almost 5 points following treatment with TBS. In a study conducted by Bologna et al., while continuous cerebellar TBS did not impact clinical outcomes in FHD and cervical dystonia patients, it reduced primary motor cortex excitability in cervical dystonia but not FHD, suggesting that the patterns of cerebellar dysfunction may vary based on the type of dystonia [31]. These non-invasive neuromodulatory studies collectively indicate that the cerebellum might play a key role in the network causing motor symptoms in dystonia. Therefore, targeting the cerebellum could be a promising area for future interventional studies.

Sokal et al. sought to explore this potential and conducted a study of 10 patients with focal or segmental dystonia secondary to cerebral palsy treated with deep anterior cerebellum stimulation (DACS). This involved the implantation of a quadripolar DBS electrode in the anterior lobe of the cerebellum. Longitudinal analysis ranging from 2–11 years after intervention revealed a significant reduction of upper extremity spasticity in 8 patients (p = 0.01), lower extremity spasticity in 7 patients (p = 0.02), and improved UDRS scores (p = 0.043) [32].

Horisawa et al. also described the use of cerebellar DBS in a case report of a 16-year-old girl with generalized fixed dystonia who had a minimal response to intrathecal baclofen therapy and bilateral pallidotomy. DBS targeting the bilateral superior cerebellar peduncles (SCPs) and dentate nuclei (DNs) was performed. The authors observed that SCP stimulation could relax muscles better than DN stimulation after two weeks of stimulation using amplitudes greater than 7V. Bilateral SCP DBS was programmed at an amplitude of 8V, a pulse width of 150 μsec, and a frequency of 200 Hz, which resulted in significant clinical improvement. The authors described the patient transforming from a preoperative bedridden state to eating and writing more independently after five months of DBS therapy [33]. Given the involvement of the SCP and DN in the dentate-thalamocortical pathway, stimulation may have modulated cortical excitability and potentially played a role in the clinical benefits [33]. These observations suggest that cerebellar DBS may also be effective in dystonia by modulating the pathologic connectivity between the cerebellum and the thalamocortical network.

In a study conducted by Cajigas et al., three patients with dyskinetic cerebral palsy, a subset of cerebral palsy highlighted by dystonia and choreoathetosis, were treated with bilateral cerebellar DBS targeting the DN and cerebellar outflow pathways. While all patients experienced a subjective improvement of motor function, the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) movement subscale response was variable, with an improvement of 19%–40% [34]. Given the damage to the basal ganglia and thalamic structures associated with cerebral palsy, the cerebellum may be an effective stimulation site for these scenarios. Currently, a series of double-blinded, randomized N-of-1 trials are being conducted to study quality of life and motor outcomes in 10 patients with dyskinetic cerebral palsy after being treated with bilateral cerebellar DBS of the DN and cerebellar outflow pathways [35].

The thalamus

Multiple studies report using VIM DBS for dystonic tremor and have observed robust clinical outcomes. In a report by Coenen et al., a 37-year-old female with a 19-year history of dystonic head tremor experienced a significant improvement (>90%) in head tremor three months after bilateral VIM DBS [36]. Similarly, improvement of dystonic tremor and fine motor skills after bilateral VIM DBS was also observed in a 25-year-old man with dystonia-choreoathetosis due to cerebral palsy, with the BFMDRS motor score and disability score improving by 13 and 4 points, respectively [37]. Since the VIM receives input from the cerebellum, as fibers travel to the motor and premotor cortices, VIM DBS may effectively treat dystonic tremor by modulating the pathological activity of the cerebello-thalamo-cortical network.

In addition to the VIM, the ventralis oralis anterior (Voa) has also been explored as a DBS target for dystonia. In a study by Mongardi et al., three patients with dystonic tremor experienced clinical benefit after Voa DBS, with all three patients observing significant improvements in their Fahn Tolosa Marin Tremor Rating Scale (FTMTRS) and BFMDRS motor scores. In patients with both tremor and dystonic features, the authors proposed the Voa as a potential DBS target over the VIM or GPi, as the Voa functions as an intersection between the cerebellothalamic and pallidothalamic pathways [38].

The thalamus may also serve as a viable DBS target for dystonia especially after suboptimal response following GPi DBS. Ghika et al. described a 26-year-old patient with generalized post-anoxic dystonia who underwent bilateral Voa DBS after marginal improvement following six weeks of bilateral GPi DBS. At 4-month follow-up, the patient experienced a reduction in dystonic symptoms and was able to walk independently with a documented UDRS improvement of 50% [39]. While a significant change was observed following Voa DBS, the response duration to GPi DBS may in many cases be delayed weeks to months, complicating the interpretation of this and other similar dystonia DBS cases in which clinical failure may be prematurely concluded in GPi DBS. An interesting point to consider is that this case report described DBS of multiple interconnected structures and potentially related nodes within the underlying pathological network. Intervening at different points within this network may lead to variations in the response time for symptomatic improvement. Further studies are needed to elucidate if these brief reports represent a common pathway and if there are equivalent responses based on the target of intervention.

In addition to the traditional VIM and Ventralis-oralis (VO) targeting, blended targeting strategies have also been explored for DBS, particularly in writer’s cramp dystonia. Cho et al. describe a case study in which a 36-year-old female with focal hand dystonia presented with right-hand tremors and sensory abnormalities. After treatment with unilateral VO complex (Voa/Vo posterior) DBS, she experienced significant clinical improvement in the BFMDRS motor score which decreased from 4 to 1 after 12 months of therapy [40]. A similar improvement was described by Fukaya et al., where five patients with treatment-resistant idiopathic writer’s cramp underwent thalamic DBS, with four patients having one lead in the VO/VIM and one patient with a lead in the GPi and VO/VIM. After 24 months of stimulation, all patients experienced a significant improvement in handwriting with the mean BFMDRS handwriting score decreasing from 3.2 to 0.2 (p < 0.001) [41]. Interestingly, bipolar stimulation of the VIM and VO yielded the greatest clinical improvement when compared with monopolar stimulation of either the VO or VIM. In the patient with two DBS leads, thalamic stimulation was continued and chosen over GPi stimulation as it resulted in improved handwriting.

Thalamic DBS has also been reported to be beneficial in myoclonus dystonia. In a report of one myoclonus dystonia patient with double mutations in the DYT-TOR1 A and DYT11 genes, bilateral VIM DBS resulted in a BFMDRS motor score decreasing from 35 to 8, the BFMDRS disability score decreasing from 17 to 5, and the Unified Myoclonus Rating Scale rest/action sub_score decreasing from 24 to 0 after six months of therapy [42].

Various studies have described GPi and thalamic DBS to treat dystonia, suggesting a synergistic effect when applying co-stimulation. Slotty et al. reported results in a single patient with hemidystonia secondary to putaminal stroke after implantation with GPi and VIM/VO DBS. Neither of the targets resulted in an improvement in the BFMDRS when evaluated individually. However, simultaneous stimulation of the VIM/VO and GPi DBS leads resulted in an improvement in the BFMDRS by 25% and the 36-Item Short Form Health Survey by 86% [43]. Chang et al. described five patients with focal or segmental upper extremity dystonia who underwent unilateral GPi and VO DBS. When comparing benefit based on target choice, the authors found that stimulating both targets was more beneficial than stimulating either target in isolation [44]. This observation was also reported by Trompette et al., where three patients with dystonic tremor underwent bilateral GPi and VIM DBS. At 1-year post-implantation, both targets were evaluated in several ON-OFF permutations (e.g. GPi ON, VIM OFF). The mean total FTMTRS and BFMDRS scores improved maximally during simultaneous GPi and VIM DBS compared to either target alone [45].

Dual lead pallidal and thalamic DBS have also been demonstrated to provide long-term benefit in dystonia. Krause et al. describe six patients with myoclonus dystonia and bilateral VIM and GPi DBS and one myoclonus dystonia patient with bilateral VIM DBS across a mean follow-up of 12 ± 1.7 years (range 7–20 years). In this study, four patients remained on pallidal stimulation at long-term follow-up and experienced a mean reduction in myoclonus of 70% and a mean improvement in motor BFMDRS of 40%. Two patients remained on VIM and GPi stimulation at long-term follow-up and experienced a mean reduction of myoclonus by 61% on the Unified Myoclonus Rating Scale and a 17.9% motor BFMDRS improvement. The patient with bilateral VIM DBS experienced a 72% improvement in myoclonus and a motor BFMDRS improvement of 50% [46].

The cortex

Researchers have also investigated noninvasive cortical-based neuromodulation techniques in dystonia cases. Although these methods affect neural tissues differently than DBS, they provide information on the dysfunctional brain networks underpinning dystonia. Insights from these studies could potentially guide the identification of new DBS targets and help fully map the brain regions involved in dystonia.

Premotor cortex

Murase et al. compared the efficacy of subthreshold low frequency (0.2 Hz for 250 stimuli) rTMS delivered to the primary motor cortex, premotor cortex, and supplementary motor area in 9 patients with FHD. The greatest improvement in handwriting was reported in 7/9 patients who received premotor cortex stimulation, which in contrast to other targets, enhanced handwriting metrics, such as the mean tracking error from the target (p = 0.004) and pen pressure (p = 0.001). Additionally, it significantly prolonged cortical silent periods (p = 0.02), indicating stronger intracortical inhibition and a potential mechanism for intervention [47]. Alternative rTMS stimulation parameters applied to the premotor cortex were also effective in treating FHD [4849].

The combined use of neuromodulation and motor training has been explored in treating focal hand dystonia, although with variable results. Souza et al. described a 46-year-old woman with FHD who experienced an improvement in dystonic symptoms after 15 sessions of rTMS of the premotor cortex followed by 30 minutes of kinesiotherapy, while Kimberley et al. reported that nine patients with FHD experienced no additional benefit of sensorimotor training when combined with rTMS of the premotor cortex [5051].

In a randomized sham-controlled study, eight patients with cervical dystonia were treated with 15-minute sessions of low-frequency rTMS (0.2 Hz) over the anterior cingulate cortex, supplementary motor area, dorsal premotor cortex, and the primary motor cortex. While all sites except the anterior cingulate cortex demonstrated an improvement in TWSTRS severity scores, the greatest improvement was observed in the dorsal premotor cortex (2.9 ± 3.4) and the primary motor cortex (3.0 ± 4.8) [52]. A similar improvement of cervical dystonia after rTMS over the premotor cortex was noted in a case described by Allam et al. [53].

Primary motor cortex

In two separate studies, the primary motor cortex was demonstrated to be effective in treating cervical dystonia. Richardson et al. reported that rTMS of the primary motor cortex in 8 cervical dystonia patients resulted in a TWSTRS improvement of 3.0 ± 4.8 [52]. When combined with kinesiotherapy, the primary motor cortex also served as an effective stimulation target for tDCS in cervical dystonia [50].

Using rTMS over the motor cortex has been observed to alleviate dystonic symptoms in FHD in both short and long-term treatment. Betti et al. described a 55-year-old man with FHD who experienced a significant improvement in motor coordination in a task resembling the dystonic-inducing symptoms and a reach-to-grasp task after five 30-minute sessions of 1 Hz rTMS [54]. Similarly, Siebner et al. found that 8/16 patients experienced a transient improvement in handwriting after 30 minutes of 1 Hz rTMS of the motor cortex [55]. Furukawa et al. sought to evaluate the immediate and long-term efficacy of rTMS. In a 40-year-old woman with FHD who was treated with 25 sessions of rTMS over one year and ten months, substantial improvements were observed with gradually lower numbers of stimulations throughout treatment [56]. In contrast with rTMS studies, Benninger et al. found no significant benefit to tDCS of the primary motor cortex in patients with FHD [57].

In a randomized study, 60 Wilson’s disease patients with upper limb dystonia received 30-minute 10 Hz rTMS sessions over the primary motor cortex or sham stimulation for seven consecutive days. After the 7th session, two weeks, and four weeks, the muscle tension and stiffness, the Modified Ashworth Scale (MAS), the Unified Wilson’s Disease Rating Scale (UWDRS), and the BFM in the treatment group were significantly lower than the control group (p < 0.01 for all) [58]. While high-frequency rTMS of the motor cortex appeared to alleviate symptoms of upper limb dystonia, Sharma et al. presented a case in which low-frequency rTMS failed to effectively treat dystonic symptoms. Although the patient tolerated the treatment well, he experienced no improvement in dystonic symptoms based on video analysis, Clinical Global Impression, and PHQ-9 scores [59].

The future of DBS for dystonia

DBS can be an effective therapy for select patients with dystonia refractory to medication. While the GPi remains the most common DBS target for the treatment of dystonia, the clinical outcomes can be variable and the programming optimization process is often challenging with benefits noted in a delayed fashion. There has been emerging evidence to suggest several novel targets may be viable for neuromodulatory therapy (Table 1). Although dystonia has historically been understood to be associated with local basal ganglia dysfunction, newer hypotheses have reframed dystonia as a network disorder that involves the basal ganglia-thalamo-cortical circuit with a significant contribution from the cerebellum [3233]. There are multiple animal models demonstrating the involvement of the cerebellum in the pathogenesis and motor dysfunction observed in dystonia, and both noninvasive cerebellar stimulation techniques including tDCS and rTMS along with invasive methods such as DBS and DACS have been found to effectively reduce dystonic symptoms. Although further studies will be needed to fully elucidate the mechanism and outcomes of cerebellar DBS in dystonia, there is growing optimism for utilizing this target.

Table 1 Overview of select studies demonstrating potential DBS targets for treating dystonia.

	
CEREBELLUM	
	
Fremont et al, Alvarez et al, LeDoux et al [232425]	Mouse and rat models have suggested the involvement of the cerebellum in the pathogenesis and motor dysfunction seen in dystonia.	
	
Bradnam et al, Nguyen et al, Bradnam et al [262728]	Cerebellar tDCS improved handwriting metrics in patients with focal hand dystonia and dystonic symptoms and pain in patients with cervical dystonia.	
	
Koch et al, Bradnam et al, Bologna et al [293031]	Continuous and intermittent theta burst stimulation using rTMS significantly decreased TWSTRS scores in cervical dystonia patients, demonstrating its ability to modulate neuroplasticity and improve dystonic symptoms. Furthermore, patterns of cerebellar dysfunction may vary based on the type of dystonia.	
	
Sokal et al. [32]	Deep anterior cerebellum stimulation significantly reduced upper and lower extremity spasticity and improved UDRS scores in patients with focal or segmental dystonia secondary to cerebral palsy.	
	
Horisawa et al. [33]	In a patient with generalized fixed dystonia, cerebellar DBS resulted in a significant clinical improvement.	
	
Cajigas et al, San Luciano et al [3435]	In 3 patients with dyskinetic cerebral palsy, bilateral cerebellar DBS targeting the DN and cerebellar outflow pathways produced subjective and objective motor function improvements.	
	
THALAMUS	
	
Coenen et al, Wolf et al [3637]	In patients with dystonic head tremor and dystonia-choreoathetosis due to cerebral palsy, VIM DBS significantly improved dystonic tremor.	
	
Mongardi et al. [38]	Patients with dystonic tremor experienced improvements in their FTMTRS and BFMDRS motor scores after Voa DBS.	
	
Ghika et al. [39]	After a suboptimal response from GPi DBS, a patient with generalized post-anoxic dystonia underwent bilateral Voa DBS that resulted in a reduction of dystonic symptoms and UDRS improvement of 50%.	
	
Cho et al, Fukaya et al [4041]	In patients with writer’s cramp dystonia, a blended strategy targeting the VIM and VO resulted in the greatest improvement of BFMDRS motor and handwriting scores.	
	
Wang et al. [60]	In a myoclonus dystonia patient with double mutations in the DYT-TOR1 A and DYT11 genes, thalamic DBS significantly improved BFMDRS motor and disability scores and the Unified Myoclonus Rating Scale rest/action subscore.	
	
MULTIPLE TARGETS	
	
Slotty et al, Chang et al, Trompette et al [434445]	In patients with hemidystonia, focal or segmental upper extremity dystonia, and dystonic tremor, dual lead pallidal and thalamic DBS resulted in greater benefit than when applying stimulation of either region individually.	
	
Krause et al [46]	Patients with myoclonus dystonia and pallidal and thalamic DBS, pallidal DBS only, and thalamic DBS only saw a reduction of myoclonus of 61.8%–72% and an improvement in motor BFMDRS of 17.9%–50% across a mean follow up of 12 ± 1.7 years (range 7–20 years).	
	
CORTEX	
	
Murase et al, Kimberley et al, Borich et al [474951]	In patients with focal hand dystonia, premotor cortex rTMS improved handwriting metrics and prolonged cortical silent periods.	
	
Souza et al, Kimberley et al [5051]	In patients with focal hand dystonia, the use of rTMS of the premotor cortex in combination with motor training has produced variable results.	
	
Richardson et al, Allam et al [5253]	In patients with cervical dystonia, rTMS of the premotor cortex resulted in a significant clinical improvement, especially compared to other stimulation sites.	
	
Richardson et al, Souza et al [5052]	Both rTMS and tDCS of the primary motor cortex were effective targets for treating cervical dystonia.	
	
Betti et al, Siebner et al, Furukawa et al, Benninger et al [54555657]	While rTMS of the motor cortex alleviated dystonic symptoms in focal hand dystonia in both short and long-term treatment, tDCS of the primary motor cortex resulted in no significant improvement in focal hand dystonia.	
	
Hao et al, Sharma et al [5859]	While high-frequency rTMS of the motor cortex was able to alleviate symptoms of upper limb dystonia, low-frequency rTMS was unable to produce an improvement.	
	

The thalamus plays an important role in motor function, given its key involvement in the basal ganglia-cerebello-thalamo-cortical circuit. Thalamic stimulation, including that of the VIM, Vop, Voa, and VLp, has been reported to be effective at improving dystonic tremor and other symptoms, especially when combined with pallidal stimulation. Specifically, we highlight observations from VIM and Voa thalamic modulation as these two sub-nuclei have been the most studied to date. The VIM receives input from the cerebellum via the dentato-rubral-thalamic tract and has been implicated in treating dystonic tremor. Furthermore, the impact of VIM DBS on dystonic tremor and the proximity of the VIM to cerebellar outflow pathways also highlight the role that the cerebellum might play in motor dysfunction in dystonia. Voa DBS has demonstrated some effectiveness in alleviating dystonic tremor and possibly other dystonic symptoms. Its impact has been attributed to its role as a node within the pallido-thalamic pathway. Combined pallidal and thalamic stimulation may synergistically affect dystonic symptoms, suggesting the potential presence of overlapping pathology of the cerebello-thalamo-cortical network in concert with the classical basal-ganglia-thalamo-cortical network.

As we consider expanding our framework of the pathological networks associated with dystonia, we highlight several studies in this review that demonstrate transient improvement in dystonia symptoms spanning from noninvasive cortical neuromodulation. These studies provide supporting evidence for the involvement of a broader network underpinning dystonia. This network remains to be fully characterized. However, as we deepen our understanding of this network, it may lead to a convergence of information for refining neuromodulation in existing DBS targets or proposing novel locations for intervention. Novel brain targets for the treatment of dystonia may hold value beyond neurotherapeutics, as their reports fill in missing pieces to the pathophysiological puzzle.

Supplemental Appendix 1

PubMed MESH search terms

((((((dystonia) AND (transcranial magnetic stimulation OR deep brain stimulation OR transcranial direct current stimulation OR transcranial alternating current stimulation OR neuromodulation))) NOT (Review[Publication Type])) NOT (Meta-Analysis[Publication Type])) NOT (Systematic Review[Publication Type])) AND (english[Language]).

Produced 5465 results on PubMed.

Funding Information

Vedant Garg, Venkat Srikar Lavu, Grace Hey, Brett Winters, Dr Firme and Dr Hilliard have no funding sources or disclosures to report.

Competing Interests

The authors have no competing interests to declare.
==== Refs
1 Albanese A, Bhatia K, Bressman SB, DeLong MR, Fahn S, Fung VSC, et al. Phenomenology and classification of dystonia: A consensus update. Mov Disord. 2013; 28 (7 ): 863–73. DOI: 10.1002/mds.25475 23649720
2 Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord Off J Mov Disord Soc. 2012 Dec; 27 (14 ): 1789–96. DOI: 10.1002/mds.25244
3 Elias GJB, Namasivayam AA, Lozano AM. Deep brain stimulation for stroke: Current uses and future directions. Brain Stimulat. 2018 Jan 1; 11 (1 ): 3–28. DOI: 10.1016/j.brs.2017.10.005
4 DeLong M, Wichmann T. Deep brain stimulation for movement and other neurologic disorders. Ann N Y Acad Sci. 2012 Aug; 1265 : 1–8. DOI: 10.1111/j.1749-6632.2012.06608.x 22823512
5 Shipton EA. Movement Disorders and Neuromodulation. Neurol Res Int. 2012; 2012 : 309431. DOI: 10.1155/2012/309431 23050143
6 Lozano AM, Eltahawy H. How does DBS work? Suppl Clin Neurophysiol. 2004; 57 : 733–6. DOI: 10.1016/S1567-424X(09)70414-3 16106676
7 Krack P, Vercueil L. Review of the functional surgical treatment of dystonia. Eur J Neurol. 2001; 8 (5 ): 389–99. DOI: 10.1046/j.1468-1331.2001.00231.x 11554902
8 Fan H, Zheng Z, Yin Z, Zhang J, Lu G. Deep Brain Stimulation Treating Dystonia: A Systematic Review of Targets, Body Distributions and Etiology Classifications. Front Hum Neurosci. 2021 Nov 26; 15 : 757579. DOI: 10.3389/fnhum.2021.757579 34899219
9 Hu W, Stead M. Deep brain stimulation for dystonia. Transl Neurodegener. 2014 Jan 21; 3 : 2. DOI: 10.1186/2047-9158-3-2 24444300
10 Ostrem JL, Starr PA. Treatment of Dystonia with Deep Brain Stimulation. Neurotherapeutics. 2008 Apr 1; 5 (2 ): 320–30. DOI: 10.1016/j.nurt.2008.01.002 18394573
11 Anderson WS, Lenz FA. Surgery Insight: deep brain stimulation for movement disorders. Nat Clin Pract Neurol. 2006 Jun; 2 (6 ): 310–20. DOI: 10.1038/ncpneuro0193 16932575
12 Kupsch A, Benecke R, Müller J, Trottenberg T, Schneider GH, Poewe W, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med. 2006; 355 (19 ): 1978–90. DOI: 10.1056/NEJMoa063618 17093249
13 Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med. 2005 Feb 3; 352 (5 ): 459–67. DOI: 10.1056/NEJMoa042187 15689584
14 Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Lagrange C, Yelnik J, et al. Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol. 2007 Mar; 6 (3 ): 223–9. DOI: 10.1016/S1474-4422(07)70035-2 17303528
15 Diamond A, Shahed J, Azher S, Dat-Vuong K, Jankovic J. Globus pallidus deep brain stimulation in dystonia. Mov Disord. 2006; 21 (5 ): 692–5. DOI: 10.1002/mds.20767 16342255
16 Humanitarian Device Exemption (HDE) [Internet]. [cited 2024 Jun 3]. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfhde/hde.cfm?id=H020007.
17 Holloway KL, Baron MS, Brown R, Cifu DX, Carne W, Ramakrishnan V. Deep Brain Stimulation for Dystonia: A Meta-Analysis. Neuromodulation Technol Neural Interface. 2006 Oct 1; 9 (4 ): 253–61. DOI: 10.1111/j.1525-1403.2006.00067.x
18 Gruber D, Trottenberg T, Kivi A, Schoenecker T, Kopp UA, Hoffmann KT, et al. Long-term effects of pallidal deep brain stimulation in tardive dystonia. Neurology. 2009; 73 (1 ): 53–8. DOI: 10.1212/WNL.0b013e3181aaea01 19564584
19 Ostrem JL, Marks WJ, Jr., Volz MM, Heath SL, Starr PA. Pallidal deep brain stimulation in patients with cranial-cervical dystonia (Meige syndrome). Mov Disord. 2007; 22 (13 ): 1885–91. DOI: 10.1002/mds.21580 17618522
20 Brodacki B, Kmiec T, Koziara H, Bonicki W, Tomasz M. Multifocal neuromodulation in generalized dystonia. J Neurol Sci. 2017 Oct; 381 : 579. DOI: 10.1016/j.jns.2017.08.1630
21 Liu Y, Zhu G, Jiang Y, Wang X, Chen Y, Meng F, et al. Comparison of Short-Term Stimulation of the Globus Pallidus Interna and Subthalamic Nucleus for Treatment of Primary Dystonia. World Neurosurg. 2019 Mar 1; 123 : e211–7. DOI: 10.1016/j.wneu.2018.11.137 30481618
22 The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | The BMJ [Internet]. [cited 2024 Jul 11]. Available from: https://www.bmj.com/content/372/bmj.n71.
23 Fremont R, Tewari A, Angueyra C, Khodakhah K. A role for cerebellum in the hereditary dystonia DYT1. Ptáček LJ, editor. eLife. 2017 Feb 15; 6 : e22775. DOI: 10.7554/eLife.22775 28198698
24 Alvarez-Fischer D, Grundmann M, Lu L, Samans B, Fritsch B, Möller JC, et al. Prolonged generalized dystonia after chronic cerebellar application of kainic acid. Brain Res. 2012 Jun 29; 1464 : 82–8. DOI: 10.1016/j.brainres.2012.05.007 22595488
25 LeDoux MS, Lorden JF, Ervin JM. Cerebellectomy Eliminates the Motor Syndrome of the Genetically Dystonic Rat. Exp Neurol. 1993 Apr 1; 120 (2 ): 302–10. DOI: 10.1006/exnr.1993.1064 8491286
26 Bradnam, LV, Graetz, LJ, McDonnell, MN, Ridding, MC. Anodal transcranial direct current stimulation to the cerebellum improves handwriting and cyclic drawing kinematics in focal hand dystonia. Front Hum Neurosci [Internet]. 2015 May 18 [cited 2024 Apr 1]; 9. Available from: https://www.frontiersin.org/articles/10.3389/fnhum.2015.00286. DOI: 10.3389/fnhum.2015.00286
27 Nguyen JP, Suarez A, Malineau C, Dixneuf V, Mazaltarine G, Damier P. Treatment of cervical dystonia and blepharospasm by anodal tDCS of cerebellar hemispheres. A case report. Neurophysiol Clin. 2020 Oct; 50 (5 ): 391–2. DOI: 10.1016/j.neucli.2020.09.006 33008674
28 Bradnam LV, Frasca J, Kimberley TJ. Direct Current Stimulation of Primary Motor Cortex and Cerebellum and Botulinum Toxin a Injections in a Person With Cervical Dystonia. Brain Stimulat. 2014 Nov; 7 (6 ): 909–11. DOI: 10.1016/j.brs.2014.09.008
29 Koch G, Porcacchia P, Ponzo V, Carrillo F, Cáceres-Redondo MT, Brusa L, et al. Effects of Two Weeks of Cerebellar Theta Burst Stimulation in Cervical Dystonia Patients. Brain Stimulat. 2014 Jul 1; 7 (4 ): 564–72. DOI: 10.1016/j.brs.2014.05.002
30 Bradnam LV, McDonnell MN, Ridding MC. Cerebellar Intermittent Theta-Burst Stimulation and Motor Control Training in Individuals with Cervical Dystonia. Brain Sci. 2016 Dec; 6 (4 ): 56. DOI: 10.3390/brainsci6040056 27886079
31 Bologna M, Paparella G, Fabbrini A, Leodori G, Rocchi L, Hallett M, et al. Effects of cerebellar theta-burst stimulation on arm and neck movement kinematics in patients with focal dystonia. Clin Neurophysiol. 2016 Nov; 127 (11 ): 3472–9. DOI: 10.1016/j.clinph.2016.09.008 27721106
32 Sokal P, Rudaś M, Harat M, Szylberg Ł, Zieliński P. Deep anterior cerebellar stimulation reduces symptoms of secondary dystonia in patients with cerebral palsy treated due to spasticity. Clin Neurol Neurosurg. 2015 Aug; 135 : 62–8. DOI: 10.1016/j.clineuro.2015.05.017 26038278
33 Horisawa S, Arai T, Suzuki N, Kawamata T, Taira T. The striking effects of deep cerebellar stimulation on generalized fixed dystonia: case report. J Neurosurg. 2020 Mar; 132 (3 ): 712–6. DOI: 10.3171/2018.11.JNS182180 30835688
34 Cajigas I, Morrison MA, Luciano MS, Starr PA. Cerebellar deep brain stimulation for the treatment of movement disorders in cerebral palsy. J Neurosurg. 2023 Sep 1; 139 (3 ): 605–14. DOI: 10.3171/2023.1.JNS222289 36789999
35 San Luciano M, Oehrn CR, Wang SS, Tolmie JS, Wiltshire A, Graff RE, et al. Protocol for combined N-of-1 trials to assess cerebellar neurostimulation for movement disorders in children and young adults with dyskinetic cerebral palsy. BMC Neurol. 2024 Apr 29; 24 (1 ): 145. DOI: 10.1186/s12883-024-03633-z 38684956
36 Coenen VA, Allert N, Mädler B. A role of diffusion tensor imaging fiber tracking in deep brain stimulation surgery: DBS of the dentato-rubro-thalamic tract (drt) for the treatment of therapy-refractory tremor. Acta Neurochir (Wien). 2011 Aug; 153 (8 ): 1579–85. DOI: 10.1007/s00701-011-1036-z 21553318
37 Wolf ME, Blahak C, Saryyeva A, Schrader C, Krauss JK. Deep brain stimulation for dystonia-choreoathetosis in cerebral palsy: Pallidal versus thalamic stimulation. Parkinsonism Relat Disord. 2019 Jun; 63 : 209–12. DOI: 10.1016/j.parkreldis.2019.01.029 30718219
38 Mongardi L, Rispoli V, Scerrati A, Giordano F, Capone JG, Vaudano AE, et al. Deep brain stimulation of the ventralis oralis anterior thalamic nucleus is effective for dystonic tremor. Parkinsonism Relat Disord. 2020 Dec; 81 : 8–11. DOI: 10.1016/j.parkreldis.2020.09.040 33035802
39 Ghika J, Villemure JG, Miklossy J, Temperli P, Pralong E, Christen–Zaech S, et al. Postanoxic generalized dystonia improved by bilateral Voa thalamic deep brain stimulation. Neurology. 2002 Jan 22; 58 (2 ): 311–3. DOI: 10.1212/WNL.58.2.311 11805266
40 Cho CB, Park HK, Lee KJ, Rha HK. Thalamic Deep Brain Stimulation for Writer’s Cramp. J Korean Neurosurg Soc. 2009; 46 (1 ): 52–5. DOI: 10.3340/jkns.2009.46.1.52 19707494
41 Fukaya C, Katayama Y, Kano T, Nagaoka T, Kobayashi K, Oshima H, et al. Thalamic deep brain stimulation for writer’s cramp. J Neurosurg. 2007; 107 (5 ): 977–82. DOI: 10.3171/JNS-07/11/0977 17977270
42 Wang JW, Li JP, Wang YP, Zhang XH, Zhang YQ. Deep brain stimulation for myoclonus-dystonia syndrome with double mutations in DYT1 and DYT11. Sci Rep. 2017 Jan 19; 7 (1 ): 41042. DOI: 10.1038/srep41042 28102337
43 Slotty PJ, Poologaindran A, Honey CR. A prospective, randomized, blinded assessment of multitarget thalamic and pallidal deep brain stimulation in a case of hemidystonia. Clin Neurol Neurosurg. 2015 Nov; 138 : 16–9. DOI: 10.1016/j.clineuro.2015.07.012 26241157
44 Chang KW, Kim MJ, Park SH, Chang WS, Jung HH, Chang JW. Dual Pallidal and Thalamic Deep Brain Stimulation for Complex Ipsilateral Dystonia. Yonsei Med J. 2022; 63 (2 ): 166–72. DOI: 10.3349/ymj.2022.63.2.166 35083902
45 Trompette C, Giordana C, Leplus A, Grabli D, Hubsch C, Marsé C, et al. Combined thalamic and pallidal deep brain stimulation for dystonic tremor. Park Relat Disord. 2022; 103 : 29–33. DOI: 10.1016/j.parkreldis.2022.08.003
46 Krause P, Koch K, Gruber D, Kupsch A, Gharabaghi A, Schneider G, et al. Long-term effects of pallidal and thalamic deep brain stimulation in myoclonus dystonia. Eur J Neurol. 2021 May; 28 (5 ): 1566–73. DOI: 10.1111/ene.14737 33452690
47 Murase N, Rothwell JC, Kaji R, Urushihara R, Nakamura K, Murayama N, et al. Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer’s cramp. Brain. 2005; 128 (Pt 1 ): 104–15. DOI: 10.1093/brain/awh315 15483042
48 Kimberley TJ, Borich MR, Arora S, Siebner HR. Multiple sessions of low-frequency repetitive transcranial magnetic stimulation in focal hand dystonia: clinical and physiological effects. Restor Neurol Neurosci. 2013; 31 (5 ): 533–42. DOI: 10.3233/RNN-120259 23340117
49 Borich M, Arora S, Kimberley TJ. Lasting effects of repeated rTMS application in focal hand dystonia. Restor Neurol Neurosci. 2009; 27 (1 ): 55–65. DOI: 10.3233/RNN-2009-0461 19164853
50 de Oliveira Souza C, Goulardins J, Coelho DB, Casagrande S, Conti J, Limongi JCP, et al. Noninvasive brain stimulation and kinesiotherapy for treatment of focal dystonia: Instrumental analysis of three cases. J Clin Neurosci. 2020; 76 : 208–10. DOI: 10.1016/j.jocn.2020.04.025 32284289
51 Kimberley, TJ, Schmidt, RLS, Chen M, Dykstra, DD, Buetefisch, CM. Mixed effectiveness of rTMS and retraining in the treatment of focal hand dystonia. Front Hum Neurosci [Internet]. 2015 Jul 9 [cited 2024 Apr 7]; 9. Available from: http://journal.frontiersin.org/Article/10.3389/fnhum.2015.00385/abstract. DOI: 10.3389/fnhum.2015.00385
52 Pirio Richardson S, Tinaz S, Chen R. Repetitive Transcranial Magnetic Stimulation in Cervical Dystonia: Effect of Site and Repetition in a Randomized Pilot Trial. Langguth B, editor. PLOS ONE. 2015 Apr 29; 10 (4 ): e0124937. DOI: 10.1371/journal.pone.0124937 25923718
53 Allam N, Brasil-Neto JP, Brandão P, Weiler F, Barros Filho J de, Tomaz C. Relief of primary cervical dystonia symptoms by low frequency transcranial magnetic stimulation of the premotor cortex: case report. Arq Neuropsiquiatr. 2007 Sep; 65 : 697–9. DOI: 10.1590/S0004-282X2007000400030 17876418
54 Betti S, Spoto A, Castiello U, Sartori L. Testing rTMS-Induced Neuroplasticity: A Single Case Study of Focal Hand Dystonia. Neural Plast. 2018 May 30; 2018 : 1–12. DOI: 10.1155/2018/6464896
55 Siebner HR, Tormos JM, Baumann AOC, Auer C, Catala MD, Conrad B, et al. Low-frequency repetitive transcranial magnetic stimulation of the motor cortex in writer’s cramp. Neurology. 1999 Feb; 52 (3 ): 529–529. DOI: 10.1212/WNL.52.3.529 10025782
56 Furukawa T, Kanke H, Masakado Y. Effects of Low-frequency Repetitive Transcranial Magnetic Stimulation on Focal Hand Dystonia: A Case Report. Tokai J Exp Clin Med. 2021; 46 (1 ): 44–50.33835475
57 Benninger DH, Lomarev M, Lopez G, Pal N, Luckenbaugh DA, Hallett M. Transcranial direct current stimulation for the treatment of focal hand dystonia. Mov Disord. 2011; 26 (9 ): 1698–702. DOI: 10.1002/mds.23691 21495074
58 Hao W, Wei T, Yang W, Yang Y, Cheng T, Li X, et al. Effects of High-Frequency Repetitive Transcranial Magnetic Stimulation on Upper Limb Dystonia in Patients With Wilson’s Disease: A Randomized Controlled Trial. Front Neurol. 2021 Dec 14; 12 : 783365. DOI: 10.3389/fneur.2021.783365 34970214
59 Sharma K, Cucca A, Lee A, Agarwal S, Frucht SJ, Biagioni MC. Transcranial magnetic stimulation therapy for focal leg dystonia: a case report. J Clin Mov Disord. 2019 Dec; 6 (1 ): 1. DOI: 10.1186/s40734-019-0076-z
60 Wang JW, Li JP, Wang YP, Zhang XH, Zhang YQ. Deep brain stimulation for myoclonus-dystonia syndrome with double mutations in DYT1 and DYT11. Sci Rep. 2017; 7 : 41042. DOI: 10.1038/srep41042 28102337
